Filing Flows › Sanara MedTech (SMTI) › Q1 2026
Sanara MedTech (SMTI) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 12, 2026
Sanara MedTech (SMTI) reported revenue of $27.8M for the first quarter 2026 (Q1 2026), +19% from a year earlier and +0.9% from the quarter before. Operating margin was 9.5%, net earnings $459K (1.6% of revenue).
Sanara MedTech, Q1 2026: revenue $27.8M (+19% year over year), operating margin 9.5%, net earnings $459K, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.8M | +0.9% | +19% |
| Gross profit | $25.9M | +0.8% | +20% |
| Operating profit | $2.6M | +152% | +221% |
| Net earnings | $459K | — | — |
| Operating cash flow | −$2.5M | -162% | — |
What changed
Revenue was $27.8M in Q1 2026, up 19% year over year and up 1% from the previous quarter. Soft Tissue Repair Products was the largest line at 90% of revenue. Soft Tissue Repair Products added $4.4M year over year (up 21%), 101% of the total change. Bone Fusion Products declined 2%.
Gross margin was 93.1%, up 0.9 points from Q1 2025. Operating profit was $2.6M, a 9.5% margin (up 6.0 points year over year). Of the extra revenue versus Q1 2025, 42% reached operating profit, above the 4% margin then. Operating expenses grew 12% against revenue growth of 19%. The fastest-growing cost line was General & admin (+21%). Net earnings were $459K. The effective tax rate was 0.0%.
Operating cash flow was −$2.5M. Non-cash charges added back $587K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items used $4.5M. Capital expenditures of $44K exceeded it, leaving free cash flow of −$2.5M.
Questions
What was Sanara MedTech's revenue in the first quarter 2026?
Sanara MedTech (SMTI) reported revenue of $27.8M for the first quarter 2026 (Q1 2026), +19% from a year earlier and +0.9% from the quarter before.
Was Sanara MedTech profitable in the first quarter 2026?
Operating profit was $2.6M (9.5% of revenue) and net earnings $459K.
Source: Sanara MedTech 10-Q on SEC EDGAR.